companies / captortherapeutics-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 38,000,00038.0M | ○ |
|---|---|---|
| founded | 2015 | |
| hq | Wroclaw, Poland | |
| industry | unknown | |
| stage | null |
Captor Therapeutics develops small-molecule drugs using targeted protein degradation to hit disease targets that conventional drugs cannot reach. It aims to treat patients with cancer and autoimmune diseases who lack good options. Its Optigrade platform pairs protein engineering, structural biology, and molecular modeling, making it one of the first European companies built on targeted protein degradation, listed on the Warsaw Stock Exchange.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-06-01 | grant | 2,700,0002.7M | null | ○ |
Nginx, UIKit, Reddit, particles.js, Python
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |